Kneuer J, Grajek I, Winkler M, Erbe S, Meinecke T, Weiss R
Circulation. 2024; 150(14):1101-1120.
PMID: 39005211
PMC: 11444369.
DOI: 10.1161/CIRCULATIONAHA.124.069315.
Sala-Hamrick K, Tapaswi A, Polemi K, Nguyen V, Colacino J
Environ Health Perspect. 2024; 132(4):47002.
PMID: 38568856
PMC: 10990114.
DOI: 10.1289/EHP12886.
Tu X, Chen L, Zheng Y, Mu C, Zhang Z, Wang F
J Exp Clin Cancer Res. 2024; 43(1):72.
PMID: 38454445
PMC: 10921725.
DOI: 10.1186/s13046-024-02985-1.
Fan R, Satilmis H, Vandewalle N, Verheye E, de Bruyne E, Menu E
Blood Cancer J. 2023; 13(1):188.
PMID: 38110349
PMC: 10728073.
DOI: 10.1038/s41408-023-00962-z.
Zhang X, Niu M, Li T, Wu Y, Gao J, Yi M
Biomark Res. 2023; 11(1):106.
PMID: 38093319
PMC: 10720252.
DOI: 10.1186/s40364-023-00548-8.
Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa.
Jin L, Chen Y, Muzaffar S, Li C, Mier-Aguilar C, Khan J
Proc Natl Acad Sci U S A. 2023; 120(49):e2315096120.
PMID: 38011564
PMC: 10710069.
DOI: 10.1073/pnas.2315096120.
Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis.
Chung Y, Ortega-Rivera O, Volckaert B, Jung E, Zhao Z, Steinmetz N
Proc Natl Acad Sci U S A. 2023; 120(43):e2221859120.
PMID: 37844250
PMC: 10614828.
DOI: 10.1073/pnas.2221859120.
S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy.
Razmkhah F, Kim S, Lim S, Dania A, Choi J
Int J Mol Sci. 2023; 24(17).
PMID: 37686186
PMC: 10488294.
DOI: 10.3390/ijms241713382.
Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
Mori S, Ishii Y, Takeuchi T, Kukimoto I
J Virol. 2023; 97(8):e0081523.
PMID: 37578237
PMC: 10506480.
DOI: 10.1128/jvi.00815-23.
S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes.
Le Boulvais Borkja M, Giambelluca M, Ytterhus B, Prestvik W, Bjorkoy G, Bofin A
Breast Cancer Res Treat. 2023; 201(2):339-350.
PMID: 37450087
PMC: 10361851.
DOI: 10.1007/s10549-023-07019-6.
Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions.
Bertolini I, Perego M, Nefedova Y, Lin C, Milcarek A, Vogel P
J Clin Invest. 2023; 133(8).
PMID: 36892943
PMC: 10104898.
DOI: 10.1172/JCI164348.
Neutrophil S100A9 supports M2 macrophage niche formation in granulomas.
Mizutani T, Ano T, Yoshioka Y, Mizuta S, Takemoto K, Ouchi Y
iScience. 2023; 26(3):106081.
PMID: 36843852
PMC: 9947307.
DOI: 10.1016/j.isci.2023.106081.
Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
Argyris P, Saavedra F, Malz C, Stone I, Wei Y, Boyle W
Oral Oncol. 2023; 137:106304.
PMID: 36608459
PMC: 9877195.
DOI: 10.1016/j.oraloncology.2022.106304.
Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer.
Sweeney C, Lazennec G, Vogel C
Front Pharmacol. 2023; 13:1095289.
PMID: 36588678
PMC: 9797527.
DOI: 10.3389/fphar.2022.1095289.
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes.
Bolouri H, Ries R, Wiedeman A, Hylkema T, Scheiding S, Gersuk V
Nat Commun. 2022; 13(1):7186.
PMID: 36418348
PMC: 9684530.
DOI: 10.1038/s41467-022-34965-4.
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC).
Rigiracciolo D, Nohata N, Lappano R, Cirillo F, Talia M, Adame-Garcia S
J Exp Clin Cancer Res. 2022; 41(1):193.
PMID: 35655319
PMC: 9164429.
DOI: 10.1186/s13046-022-02396-0.
Newly identified breast luminal progenitor and gestational stem cell populations likely give rise to HER2-overexpressing and basal-like breast cancers.
McMullen J, Soto U
Discov Oncol. 2022; 13(1):38.
PMID: 35633393
PMC: 9148339.
DOI: 10.1007/s12672-022-00500-6.
MafB, WDR77, and ß-catenin interact with each other and have similar genome association profiles.
He L, Gao M, Pratt H, Weng Z, Struhl K
PLoS One. 2022; 17(4):e0264799.
PMID: 35482762
PMC: 9049301.
DOI: 10.1371/journal.pone.0264799.
Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer.
Biswas A, Han S, Tai Y, Ma W, Coker C, Quinn S
Cancer Discov. 2022; 12(4):1002-1021.
PMID: 35078784
PMC: 8983473.
DOI: 10.1158/2159-8290.CD-21-0910.
Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model.
Nguyen Y, Fujisawa M, Nguyen T, Suehara Y, Sakamoto T, Matsuoka R
Cancer Sci. 2021; 112(12):4931-4943.
PMID: 34657351
PMC: 8645781.
DOI: 10.1111/cas.15165.